MIDLOTHIAN, Va., July 21 /PRNewswire/ -- Today, PARI Respiratory Equipment was granted a US Patent for its Vortex Holding Chamber, a unique, non-electrostatic, holding chamber with a one piece, dual-valve system that optimizes patient inhalation and exhalation for more efficient medication delivery with a metered dose inhaler (MDI).
"Innovations like the Vortex Holding Chamber truly enhance respiratory care by making therapies easier for patients. We are very pleased that the Vortex Holding Chamber has been granted this US patent, because the Vortex Holding Chamber ensures patients do not have to worry about coordinating their breaths when using a MDI to get an effective treatment. This enhances drug delivery, minimizes drug delivered to the throat, and allows low resistance inhalation and exhalation with the device," added Geoff A. Hunziker, president of PARI Respiratory Equipment.
About PARI Respiratory Equipment, Inc.
PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's worldwide vision is to improve the lives of those affected by respiratory diseases and those who care for them.
Additional information is available by contacting Kirsten Ayars at 805-845-5682 or Ashley Weigand at 804-253-7274 x711.
PARI Respiratory Equipment, Inc.
